Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS: EIGRQ · Delayed Price · USD
+1.25 (10.82%)
Jun 25, 2024, 1:36 PM EDT - Market open

Eiger BioPharmaceuticals Statistics

Total Valuation

EIGRQ has a market cap or net worth of $18.95 million. The enterprise value is $34.64 million.

Market Cap 18.95M
Enterprise Value 34.64M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

EIGRQ has 1.48 million shares outstanding. The number of shares has increased by 6.39% in one year.

Shares Outstanding 1.48M
Shares Change (YoY) +6.39%
Shares Change (QoQ) +0.15%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.20
Forward PS 0.73
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.20
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.71

Current Ratio 0.71
Quick Ratio 0.51
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.71

Financial Efficiency

Return on equity (ROE) is -869.80% and return on invested capital (ROIC) is -268.41%.

Return on Equity (ROE) -869.80%
Return on Assets (ROA) -112.70%
Return on Capital (ROIC) -268.41%
Revenue Per Employee $630,920
Profits Per Employee -$3.00M
Employee Count 25
Asset Turnover 0.24
Inventory Turnover 0.01


In the past 12 months, EIGRQ has paid $6,000 in taxes.

Income Tax 6,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -47.86% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -47.86%
50-Day Moving Average 3.01
200-Day Moving Average 6.61
Relative Strength Index (RSI) 89.99
Average Volume (20 Days) 27,649

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, EIGRQ had revenue of $15.77 million and -$74.96 million in losses. Loss per share was -$50.78.

Revenue 15.77M
Gross Profit 15.75M
Operating Income -71.79M
Pretax Income -74.96M
Net Income -74.96M
EBITDA -68.74M
EBIT -69.49M
Loss Per Share -$50.78
Full Income Statement

Balance Sheet

The company has $25.44 million in cash and $41.20 million in debt, giving a net cash position of -$15.76 million or -$10.64 per share.

Cash & Cash Equivalents 25.44M
Total Debt 41.20M
Net Cash -15.76M
Net Cash Per Share -$10.64
Equity / Book Value -14.46M
Book Value Per Share -9.76
Working Capital -15.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$74.55 million and capital expenditures -$234,000, giving a free cash flow of -$74.78 million.

Operating Cash Flow -74.55M
Capital Expenditures -234,000
Free Cash Flow -74.78M
FCF Per Share -$50.66
Full Cash Flow Statement


Gross margin is 99.85%, with operating and profit margins of -455.12% and -475.26%.

Gross Margin 99.85%
Operating Margin -455.12%
Pretax Margin -475.22%
Profit Margin -475.26%
EBITDA Margin -435.81%
EBIT Margin -440.57%
FCF Margin -474.11%

Dividends & Yields

EIGRQ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.39%
Shareholder Yield -6.39%
Earnings Yield -397.05%
FCF Yield -396.09%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


EIGRQ has an Altman Z-Score of -24.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -24.23
Piotroski F-Score 3